Oxurion NV (EBR:OXUR)
Belgium · Delayed Price · Currency is EUR 0.0044
+0.0004 (10.00%)
Apr 10, 2026, 5:35 PM CET
Oxurion NV Market Cap
Oxurion NV has a market cap or net worth of €390.24 thousand as of April 10, 2026. Its market cap has decreased by -32.64% in one year.
Market Cap
390.24K
Enterprise Value
11.21M
Revenue
2.00K
Ranking
n/a
PE Ratio
0.01
Stock Price
€0.00
Market Cap Chart
Since July 7, 2006, Oxurion NV's market cap has decreased from 100.46M to 390.24K, a decrease of -99.61%. That is a compound annual growth rate of -24.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 308.43K | -31.57% |
| Dec 31, 2025 | 450.71K | -41.17% |
| Dec 31, 2024 | 766.13K | -73.79% |
| Dec 29, 2023 | 2.92M | -62.57% |
| Dec 30, 2022 | 7.81M | -88.99% |
| Dec 31, 2021 | 70.93M | -27.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 52.35B |
| argenx SE | 42.41B |
| Financière de Tubize | 10.06B |
| Onward Medical | 173.63M |
| Hyloris Pharmaceuticals | 134.40M |
| European Medical Solutions | 22.22M |
| Celyad Oncology | 14.10M |
| BioSenic | 1.57M |